![Frontiers | RNASE2 Mediates Age-Associated B Cell Expansion Through Monocyte Derived IL-10 in Patients With Systemic Lupus Erythematosus Frontiers | RNASE2 Mediates Age-Associated B Cell Expansion Through Monocyte Derived IL-10 in Patients With Systemic Lupus Erythematosus](https://www.frontiersin.org/files/Articles/752189/fimmu-13-752189-HTML-r1/image_m/fimmu-13-752189-g002.jpg)
Frontiers | RNASE2 Mediates Age-Associated B Cell Expansion Through Monocyte Derived IL-10 in Patients With Systemic Lupus Erythematosus
![Episode 219-Pathfinder-The Kobald Lair Part 6-Will Grak be able to climb a wall/Beano's bet of Destiny by Conversations About... Episode 219-Pathfinder-The Kobald Lair Part 6-Will Grak be able to climb a wall/Beano's bet of Destiny by Conversations About...](https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode400/2455692/2455692-1678425839194-9c2bebe47758c.jpg)
Episode 219-Pathfinder-The Kobald Lair Part 6-Will Grak be able to climb a wall/Beano's bet of Destiny by Conversations About...
Regulation of B cell function and expression of CD11c, T-bet, and FcLR5 after infection and in response to different activation
![Cancers | Free Full-Text | Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers Cancers | Free Full-Text | Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers](https://pub.mdpi-res.com/cancers/cancers-14-04474/article_deploy/html/images/cancers-14-04474-ag.png?1663572665)
Cancers | Free Full-Text | Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers
![PDF) Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers PDF) Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers](https://i1.rgstatic.net/publication/363590228_Enhanced_Antitumoral_Activity_of_Encapsulated_BET_Inhibitors_When_Combined_with_PARP_Inhibitors_for_the_Treatment_of_Triple-Negative_Breast_and_Ovarian_Cancers/links/6324749e0a70852150fb4505/largepreview.png)
PDF) Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers
![Age-associated B cells are long-lasting effectors that impede latent γHV68 reactivation | Scientific Reports Age-associated B cells are long-lasting effectors that impede latent γHV68 reactivation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-25543-1/MediaObjects/41598_2022_25543_Fig4_HTML.png)
Age-associated B cells are long-lasting effectors that impede latent γHV68 reactivation | Scientific Reports
![Age-associated B cells are long-lasting effectors that impede latent γHV68 reactivation | Scientific Reports Age-associated B cells are long-lasting effectors that impede latent γHV68 reactivation | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-25543-1/MediaObjects/41598_2022_25543_Fig2_HTML.png)